Management of phosphate abnormalities in hemodialysis patients : findings from Malaysia
المؤلف
Koya, Saiful Nizam M. V Muhammad
المصدر
Saudi Journal of Kidney Diseases and Transplantation
العدد
المجلد 30، العدد 3 (30 يونيو/حزيران 2019)، ص ص. 670-677، 8ص.
الناشر
تاريخ النشر
2019-06-30
دولة النشر
السعودية
عدد الصفحات
8
التخصصات الرئيسية
الموضوعات
الملخص EN
Studies have shown that the mean or median phosphate levels were related to certain factors although applying this finding into the clinical setting is challenging.
In this study, we attempted to determine treatment characteristics for patients with end-stage renal disease (ESRD) on maintenance hemodialysis (MHD) having hyperphosphatemia or hypophosphatemia in comparison with those with normal phosphate level.
This was a cross-sectional survey conducted at HD units of Central Pahang Cluster Hospitals, Malaysia, in April 2017 involving 110 ESRD patients on MHD.
About 40% of the study patients had normo- or hyperphosphatemia.
As many as 84.5% (n = 93) of our patients were prescribed calcium carbonate (CC); the phosphate level was not affected by phosphate binder (PB) adherence.
None of our patients received more than one type of PBs.
Although there were no significant differences in any factors between normo- and hyperphosphatemic patients, 64% (n = 28) of the hyperphosphatemic patients did not receive the recommended maximum PB dose.
In addition, 42% (n = 30) of patients with normo- and hyperphosphatemia prescribed CC received more than the recommended daily elemental calcium.
On the other hand, our hypophosphatemic patients tended to be significantly older and had lower HD duration compared to normophosphatemic patients.
No other significant differences were found in medication factors between normo- and hypophosphatemic patients.
There is potential to maximize phosphate control in hyperphosphatemic patients in Malaysia by maximizing PB therapy.
On the other hand, proactive supervision is required in caring and prescribing for hypophosphatemic patients, especially the older patients.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Koya, Saiful Nizam M. V Muhammad. 2019. Management of phosphate abnormalities in hemodialysis patients : findings from Malaysia. Saudi Journal of Kidney Diseases and Transplantation،Vol. 30, no. 3, pp.670-677.
https://search.emarefa.net/detail/BIM-894148
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Koya, Saiful Nizam M. V Muhammad. Management of phosphate abnormalities in hemodialysis patients : findings from Malaysia. Saudi Journal of Kidney Diseases and Transplantation Vol. 30, no. 3 (May. / Jun. 2019), pp.670-677.
https://search.emarefa.net/detail/BIM-894148
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Koya, Saiful Nizam M. V Muhammad. Management of phosphate abnormalities in hemodialysis patients : findings from Malaysia. Saudi Journal of Kidney Diseases and Transplantation. 2019. Vol. 30, no. 3, pp.670-677.
https://search.emarefa.net/detail/BIM-894148
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 676-677
رقم السجل
BIM-894148
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر